Terns Pharmaceuticals (TERN) Provides Program Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. JNJ
2. SUNS
3. OIG
4. NRIX
5. ACI
6. SPY
7. SNDX
8. HUM
9. META
10. MRK

Go back to Terns Pharmaceuticals (TERN) Provides Program Updates

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

February 25, 2025 8:05 AM EST

TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25

New TERN-701 data from ongoing U.S. healthy volunteer PK study shows improved drug-drug interaction profile compared to asciminib

Introduces TERN-601 Phase 2 FALCON obesity study design; on track to initiate study in early 2Q25 with 12-week data expected 2H25

Cash and cash equivalents expected to provide runway into 2028

FOSTER CITY, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (Terns or the Company) (Nasdaq:... More